Potentially, BRAF mutation analysis of sentinel lymph node (SLN) biopsies could enhance the detection of micrometastases and improve the accuracy of nodal staging for patients with melanoma.

• 理论上，对前哨淋巴结(SLN)的活检组织进行BRAF基因突变分析，能提高淋巴结微转移的检出率和黑色素瘤患者淋巴结分期的精确度。